VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SANA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SANASana Biotechnology, Inc.
$4.12$1.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSANAQuarterly Financials

Sana Biotechnology, Inc. (SANA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Sana Biotechnology, Inc. (SANA) quarterly income statement — complete revenue, gross profit & net income history

SANA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold2.39M0000000000000000000
COGS % of Revenue--------------------
Gross Profit-2.39M0000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses35.48M61.2M43.52M94.97M50.63M50.87M61.76M49.37M110.72M90.62M2.18M116.29M84.05M81.79M86.19M72.9M31.68M111.28M83.43M-18.55M
OpEx % of Revenue--------------------
Selling, General & Admin11.46M12.19M10.29M10.34M11.48M17.28M14.05M16.44M16.27M20.78M19.18M16.57M16.77M23.32M15.51M18.29M14.43M12.68M13.43M12.48M
SG&A % of Revenue--------------------
Research & Development24.02M49.01M33.23M40.02M39.15M33.59M47.71M32.93M94.45M69.83M-17M99.72M67.29M58.47M70.67M54.61M17.25M98.6M70M-31.03M
R&D % of Revenue--------------------
Other Operating Expenses0001000K0000000000000000
Operating Income-37.87M-61.2M-43.52M-94.97M-50.63M-50.87M-61.76M-49.37M-110.72M-90.62M-2.18M-116.29M-84.05M-81.79M-86.19M-72.9M-31.68M-111.28M-83.43M18.55M
Operating Margin %--------------------
Operating Income Growth %25.2%-20.31%29.54%-92.37%54.27%43.87%-2731.77%57.54%-31.73%-10.8%97.47%-59.51%-165.27%26.5%-3.3%-492.97%82.47%1.8%-61.55%-
EBITDA-35.48M-58.15M-40.32M-92.12M-46.98M-45.17M-57.7M-45.48M-106.98M-79.36M2.32M-111.84M-79.71M-77.59M-82.17M-69.1M-28.07M-107.94M-80.55M21.16M
EBITDA Margin %--------------------
EBITDA Growth %24.48%-28.72%30.12%-102.56%56.08%43.07%-2589.39%59.34%-34.22%-2.27%102.82%-61.84%-183.94%28.12%-2.01%-426.61%84.27%3.25%-60.7%-
D&A (Non-Cash Add-back)2.39M3.05M3.19M2.86M3.65M5.69M4.06M3.9M3.75M11.26M4.5M4.45M4.35M4.2M4.02M3.8M3.61M3.33M2.88M2.61M
EBIT-37.87M-61.2M-42.15M-50.36M-50.63M-50.87M-61.76M-49.37M-110.72M-90.62M-2.18M-116.29M-84.05M-81.79M-86.19M-72.9M-31.68M-111.28M-83.43M18.55M
Net Interest Income951K-1.57M1M577K992K1.66M2.58M3.2M3.03M2.73M2.86M2.37M1.98M1.61M1.17M637K339K267K158K130K
Interest Income951K-1.57M1M577K992K1.66M2.58M3.2M3.03M2.73M2.86M2.37M1.98M1.61M1.17M637K339K267K158K130K
Interest Expense00000000000000000000
Other Income/Expense-9.34M2.37M1.36M1.18M1.24M1.8M1.84M-919K3.25M2.5M3.17M2.29M1.93M1.34M1.07M439K237K548K168K131K
Pretax Income-47.21M-58.83M-42.15M-93.8M-49.39M-49.07M-59.92M-50.29M-107.47M-88.12M984K-114M-82.12M-80.44M-85.12M-72.47M-31.45M-110.73M-83.26M18.68M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-47.21M-58.83M-42.15M-93.8M-49.39M-49.07M-59.92M-50.29M-107.47M-88.12M984K-114M-82.12M-80.44M-85.12M-72.47M-31.45M-110.73M-83.26M18.68M
Net Margin %--------------------
Net Income Growth %4.41%-19.88%29.66%-86.51%54.05%44.31%-6189.84%55.88%-30.87%-9.54%101.16%-57.32%-161.14%27.35%-2.23%-487.87%82.59%2.16%-61.83%-
Net Income (Continuing)-47.21M-58.83M-42.15M-93.8M-49.39M-49.07M-59.92M-50.29M-107.47M-88.12M984K-114M-82.12M-80.44M-85.12M-72.47M-31.45M-110.73M-83.26M18.68M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.17-0.20-0.16-0.39-0.21-0.21-0.25-0.21-0.49-0.450.00-0.59-0.43-0.42-0.45-0.39-0.17-0.60-0.460.09
EPS Growth %19.05%4.76%36%-85.71%57.14%53.33%-64.41%-13.95%-7.14%101.09%-51.28%-152.94%30%2.17%-533.33%82.83%7.69%-17.95%-
EPS (Basic)-0.17-0.21-0.16-0.39-0.21-0.21-0.25-0.21-0.49-0.450.01-0.59-0.43-0.42-0.45-0.39-0.17-0.60-0.460.10
Diluted Shares Outstanding276.86M253.23M260.49M238.41M237.58M236.3M235.41M234.44M217.29M197.32M200.47M192.54M191.23M190.42M189.3M187.63M185.96M183.99M181.83M190.51M
Basic Shares Outstanding276.86M253.23M260.49M238.41M237.58M236.3M235.41M234.44M217.29M197.32M196.98M192.54M191.23M190.42M189.3M187.63M185.96M183.99M181.83M179.9M
Dividend Payout Ratio--------------------